Cite
MLA Citation
Nilanjana Maulik et al.. “Reply to the letter "thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction".” International journal of cardiology, vol. 207, 2016, pp. 277–278. http://access.bl.uk/ark:/81055/vdc_100030690401.0x000028